<SEC-DOCUMENT>0001104659-21-054481.txt : 20210423
<SEC-HEADER>0001104659-21-054481.hdr.sgml : 20210423
<ACCEPTANCE-DATETIME>20210423163126
ACCESSION NUMBER:		0001104659-21-054481
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210423
DATE AS OF CHANGE:		20210423

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Farmmi, Inc.
		CENTRAL INDEX KEY:			0001701261
		STANDARD INDUSTRIAL CLASSIFICATION:	CANNED, FRUITS, VEG & PRESERVES, JAMS & JELLIES [2033]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-254397
		FILM NUMBER:		21850237

	BUSINESS ADDRESS:	
		STREET 1:		FL 1, BUILDING NO. 1
		STREET 2:		888 TIANNING STREET, LIANDU DISTRICT
		CITY:			LISHUI, ZHEJIANG PROVINCE
		STATE:			F4
		ZIP:			323000
		BUSINESS PHONE:		86-0578-82612876

	MAIL ADDRESS:	
		STREET 1:		FL 1, BUILDING NO. 1
		STREET 2:		888 TIANNING STREET, LIANDU DISTRICT
		CITY:			LISHUI, ZHEJIANG PROVINCE
		STATE:			F4
		ZIP:			323000
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>tm2113755-1_424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed pursuant to Rule 424(b)(3)</B></P>

<P STYLE="text-align: right; margin: 0pt 0"><B>File No. 333-254397</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm2113755-1_424b3img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FARMMI,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1,039,329 Ordinary Shares underlying
Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus relates to the resale, from time to time, by
the selling shareholder (the &ldquo;Selling Shareholder&rdquo;) identified in this prospectus under the caption &ldquo;Selling
Shareholder,&rdquo; of up to 1,039,329 of our ordinary shares (the &ldquo;Shares&rdquo;), par value $0.001 per share, issuable
upon exercise of certain outstanding warrants issued and sold by us. We are not selling any ordinary shares under this prospectus
and will not receive any proceeds from the sale of the Shares by the Selling Shareholder. We will receive proceeds from any exercise
of the warrants, which, if exercised in cash with respect to all of the 1,039,329 ordinary shares offered hereby, would result
in gross proceeds to us of $2,078,658; however, we cannot predict when or if the warrants will be exercised and it is possible
that the warrants may expire and never be exercised, in which case we would not receive any cash proceeds. We have agreed to bear
all of the expenses incurred in connection with the registration of the Shares. The Selling Shareholder will bear
all commissions and discounts, if any, attributable to the sale of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Selling Shareholder may sell the Shares offered by this
prospectus from time to time on terms to be determined at the time of sale through ordinary brokerage transactions or through any
other means described in this prospectus under the caption &ldquo;Plan of Distribution.&rdquo; The Shares may be sold at fixed
prices, at market prices prevailing at the time of sale, at prices related to prevailing market price or at negotiated prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our ordinary shares are listed on the Nasdaq Capital Market
under the symbol &ldquo;FAMI.&rdquo; On March&nbsp;15, 2021, the closing price of our ordinary shares was $1.54 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are an &ldquo;emerging growth company&rdquo; under the federal
securities laws and will be subject to reduced public company reporting requirements. Investing in our ordinary shares involves
risks. See &ldquo;Risk Factors&rdquo; beginning on page <U>7</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is April 16, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 87%; text-align: left"><A HREF="#a_001">PROSPECTUS SUMMARY</A></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><A HREF="#a_001">2</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_002">INFORMATION REGARDING FORWARD-LOOKING
    STATEMENTS; CAUTIONARY LANGUAGE</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_002">4</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_003">ABOUT OUR COMPANY</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_003">5</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_004">THE OFFERING</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_004">6</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_005">RISK FACTORS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_005">7</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_006">USE OF PROCEEDS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_006">9</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_007">PRIVATE PLACEMENT</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_007">10</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_009">PLAN OF DISTRIBUTION</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_009">13</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_010">EXPENSES RELATING TO THIS OFFERING</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_010">15</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_011">LEGAL MATTERS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_011">15</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_012">EXPERTS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_012">15</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_013">ENFORCEABILITY OF CIVIL LIABILITIES
    UNDER UNITED STATES FEDERAL SECURITIES&nbsp;LAWS AND OTHER MATTERS</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_013">15</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_014">DISCLOSURE OF COMMISSION POSITION
    ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_014">16</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_015">WHERE YOU CAN FIND MORE INFORMATION</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_015">16</A></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_016">INFORMATION INCORPORATED BY REFERENCE</A></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_016">16</A></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>You should rely only on the information contained or incorporated
by reference in this prospectus or any prospectus supplement. We have not authorized any person to provide you with different or
additional information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus
is not an offer to sell securities, and it is not soliciting an offer to buy securities in any jurisdiction where the offer or
sale is not permitted. You should assume that the information appearing in this prospectus or any prospectus supplement, as well
as information we have previously filed with the SEC and incorporated by reference, is accurate as of the date on the front of
those documents only. Our business, financial condition, results of operations and prospects may have changed since those dates.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1pt solid; padding-right: 5pt; padding-left: 5pt; width: 98%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus is part of a registration statement that we
filed with the Securities and Exchange Commission, or SEC. You should read carefully both this prospectus and any prospectus supplement
together with additional information described below under the caption &ldquo;Where You Can Find More Information,&rdquo; before
making an investment decision. We have incorporated exhibits into this registration statement. You should read the exhibits carefully
for provisions that may be important to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Industry data and other statistical information used in this
prospectus, any applicable prospectus supplement, any related free writing prospectus and any document incorporated by reference
into this prospectus are based on independent publications, reports by market research firms or other published independent sources.
Some data are also based on our good faith estimates, derived from our review of internal surveys and the independent sources listed
above. Although we believe these sources are reliable, we have not independently verified the information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You should rely only on the information contained or incorporated
by reference in this prospectus or any prospectus supplement. We have not authorized any person to provide you with different or
additional information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus
is not an offer to sell securities, and it is not soliciting an offer to buy securities in any jurisdiction where the offer or
sale is not permitted. You should assume that the information appearing in this prospectus or any prospectus supplement, as well
as information we have previously filed with the SEC and incorporated by reference, is accurate as of the date on the front of
those documents only. Our business, financial condition, results of operations and prospects may have changed since those dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Selling Shareholder may sell our ordinary shares to underwriters
who will sell the securities to the public at a fixed offering price or at varying prices determined at the time of sale. The applicable
prospectus supplement will contain the names of the underwriters, dealers or agents, if any, together with the terms of offering
and the compensation of those underwriters, dealers or agents. Any underwriters, dealers or agents participating in the offering
may be deemed &ldquo;underwriters&rdquo; within the meaning of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Except as otherwise indicated by the context, references in
this prospectus to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>&ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our company,&rdquo; &ldquo;our&rdquo; and &ldquo;Farmmi&rdquo; refer to</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Farmmi,&nbsp;Inc., a Cayman Islands company limited by shares
        (&ldquo;FMI&rdquo; when individually referenced);</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Farmmi International Limited, a Hong Kong limited company (&ldquo;Farmmi
        International&rdquo; when individually referenced), which is a wholly owned subsidiary of FMI;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Farmmi (Hangzhou) Enterprise Management Co.,&nbsp;Ltd., a PRC
        company (&ldquo;Farmmi Enterprise&rdquo;) (also referred to as &#20892;&#31859;&#65288;&#26477;&#24030;&#65289;&#20225;&#19994;&#31649;&#29702;&#26377;&#38480;&#20844;&#21496;
        in Chinese), which is a wholly owned subsidiary of Farmmi International;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lishui Farmmi Technology Co.,&nbsp;Ltd., a PRC company (&ldquo;Farmmi
        Technology&rdquo;) (also referred to as &#20029;&#27700;&#20892;&#31859;&#31185;&#25216;&#26377;&#38480;&#20844;&#21496; in Chinese),
        which is a wholly owned subsidiary of Farmmi International;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hangzhou Suyuan Agriculture Technology Co.,&nbsp;Ltd., a PRC
        company (&ldquo;Suyuan Agriculture&rdquo;) (also referred to as &#26477;&#24030;&#32032;&#28304;&#20892;&#19994;&#31185;&#25216;&#26377;&#38480;&#20844;&#21496;
        in Chinese), 50% of which is owned by Farmmi Enterprise and 50% of which is owned by Farmmi Technology;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P></div>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1pt solid; padding-right: 5pt; padding-left: 5pt; width: 98%"><P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hangzhou Nongyuan Network Technology Co.,&nbsp;Ltd., a PRC company
        (&ldquo;Nongyuan Network&rdquo;) (also referred to as &#26477;&#24030;&#20892;&#28304;&#32593;&#32476;&#31185;&#25216;&#26377;&#38480;&#20844;&#21496;
        in Chinese), which is wholly owned by Ms.&nbsp;Xinyang Wang, a PRC citizen and wholly controlled by Suyuan Agriculture through
        VIE;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Zhejiang FLS Mushroom Co.,&nbsp;Ltd., a PRC company (&ldquo;FLS
        Mushroom&rdquo;) (also referred to as &#27993;&#27743;&#23500;&#26469;&#26862;&#39135;&#29992;&#33740;&#26377;&#38480;&#20844;&#21496;
        in Chinese), which is a wholly owned subsidiary of Suyuan Agriculture;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Zhejiang Forest Food Co.,&nbsp;Ltd., a PRC company (&ldquo;Forest
        Food&rdquo;) (also referred to as &#27993;&#27743;&#23500;&#26469;&#26862;&#39135;&#21697;&#26377;&#38480;&#20844;&#21496; in Chinese),
        which is a 96.15%-owned subsidiary of Suyuan Agriculture, the remaining 3.85% of Forest Food being held by Hangzhou Dawo Software
        Ltd. Co. (&ldquo;Dawo&rdquo;), a PRC company and a non-affiliated third party;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Zhejiang Farmmi Food Co.,&nbsp;Ltd., a PRC company
        (&ldquo;Farmmi Food&rdquo;) (also referred to as
        &#27993;&#27743;&#20892;&#31859;&#39135;&#21697;&#26377;&#38480;&#20844;&#21496; in Chinese), which is a wholly owned
        subsidiary of Suyuan Agriculture; and</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>Lishui Farmmi E-Commerce Co.,&nbsp;Ltd., a PRC company (&ldquo;<FONT STYLE="color: #181717">Farmmi E-Commerce</FONT>&rdquo;) (also referred to as &#20029;&#27700;&#20892;&#31859;&#30005;&#23376;&#21830;&#21153;&#26377;&#38480;&#20844;&#21496; in Chinese), which is 98% owned by Nongyuan Network and 2% owned by Suyuan Agriculture.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>all references to &ldquo;RMB,&rdquo; &ldquo;Renminbi&rdquo; and &ldquo;&yen;&rdquo; are to the legal currency of China and all references to &ldquo;USD,&rdquo; &ldquo;U.S. dollars,&rdquo; &ldquo;dollars,&rdquo; and &ldquo;$&rdquo; are to the legal currency of the United States; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>&ldquo;China&rdquo; and &ldquo;PRC&rdquo; refer to the People&rsquo;s Republic of China, and for the purpose of this prospectus only, excluding Taiwan, Hong Kong and Macau.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1pt solid; padding-right: 5pt; padding-left: 5pt; width: 98%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>INFORMATION REGARDING FORWARD-LOOKING
STATEMENTS; CAUTIONARY LANGUAGE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This prospectus, any applicable prospectus supplement, any related
free writing prospectus and any document incorporated by reference into this prospectus contain, or will contain, forward-looking
statements within the meaning of the &ldquo;safe harbor&rdquo; provisions of the United States Private Securities Litigation Reform
Act of 1995, or the PSLRA. In addition, we, or our executive officers on our behalf, may from time to time make forward-looking
statements in reports and other documents we file with the SEC or in connection with oral statements made to the press, potential
investors or others. Forward-looking statements include all statements that are not statements of historical facts and may relate
to, but are not limited to, expectations or estimates of future operating results or financial performance, capital expenditures,
regulatory compliance, plans for growth and future operations, as well as assumptions relating to the foregoing. In some cases,
you can identify forward-looking statements by terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo;
 &ldquo;could,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo;
 &ldquo;predict,&rdquo; &ldquo;intend,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue&rdquo; or the negative of these terms or
other similar terminology. Although we do not make forward-looking statements unless we believe we have a reasonable basis for
doing so, we cannot guarantee their accuracy, and actual results may differ materially from those we anticipated due to a number
of uncertainties, many of which cannot be foreseen. Our actual results could differ materially from those anticipated in these
forward-looking statements for many reasons, including, but not limited to, the risks and uncertainties described in the section
entitled &ldquo;Risk Factors&rdquo; in this prospectus, in any applicable prospectus supplement, any related free writing prospectus
and in any document incorporated by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We believe that it is important to communicate our future expectations
to potential investors. However, there may be events in the future that we are not able to accurately predict or control and that
may cause actual events or results to differ materially from the expectations expressed in or implied by our forward-looking statements.
The risks and uncertainties described in the section entitled &ldquo;Risk Factors&rdquo; in this prospectus, in any applicable
prospectus supplement, any related free writing prospectus and in any document incorporated by reference into this prospectus provide
examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we describe
in our forward-looking statements. Before you invest in our securities, you should be aware that the occurrence of these risks
and uncertainties could negatively impact, among other things, our business, cash flows, results of operations, financial condition
and share price. Potential investors should not place undue reliance on our forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Forward-looking statements regarding our present plans or expectations
for sales, supply contracts, purchases, sources and availability of financing, and growth involve risks and uncertainties relative
to return expectations and related allocation of resources, and changing economic or competitive conditions, as well as the negotiation
of agreements with suppliers and customers, which could cause actual results to differ from present plans or expectations, and
such differences could be material. Similarly, forward-looking statements regarding our present expectations for operating results
and cash flow involve risks and uncertainties related to factors such as utilization rates, material prices, demand for products
by our customers, supply and other factors described in the section entitled &ldquo;Risk Factors&rdquo; in this prospectus, in
any applicable prospectus supplement, any related free writing prospectus and in any document incorporated by reference into this
prospectus, which would also cause actual results to differ from present plans. Such differences could be material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All future written and oral forward-looking statements attributable
to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred
to in this section. Forward-looking statements speak only as of the date the statements are made. New risks and uncertainties arise
from time to time, and we cannot predict those events or how they may affect us. We assume no obligation to, and do not plan to,
update any forward-looking statements as a result of new information, future events or developments, except as required by U.S.
federal securities laws. You should read this prospectus, any applicable prospectus supplement, any related free writing prospectus
and any document incorporated by reference into this prospectus with the understanding that we cannot guarantee future results,
levels of activity, performance or achievements and that actual results may differ materially from what we expect. The forward-looking
statements contained in this prospectus, any applicable prospectus supplement, any related free writing prospectus and any document
incorporated by reference into this prospectus are excluded from the safe harbor protection provided by the PSLRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1pt solid; padding-right: 5pt; padding-left: 5pt; width: 98%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>ABOUT OUR COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In the fiscal year ended September&nbsp;30,
2020, we mainly process and/or sell four categories of agricultural products: Shiitake mushrooms, Mu Er mushrooms, other edible
fungi, and other agricultural products. We do not grow fungi, but purchase dried edible fungi from third party suppliers, mainly
from family farms, and two co-operatives representing family farms, Jingning Liannong Trading Co. Ltd. (&ldquo;JLT&rdquo;) and
Qingyuan Nongbang Mushroom Industry Co.,&nbsp;Ltd. (&ldquo;QNMI&rdquo;), with whom we have worked with for many years. JLT and
QNMI are two companies in the Lishui area where our facilities are located. They are co-operatives representing family farms which
plant and provide edible fungi. JLT and QNMI themselves do not have any facilities and do not process any fungi. They are established
to share resources such as procurement information and to enjoy the advantage of economy of scale. After we select and filter the
dried edible fungi for specific size and quality from our suppliers, we may further dehydrate them again, as deemed necessary,
to ensure uniform moisture level of our products. We then package the fungi products for sale. The only products we process and
package are edible fungi, which are processed and packaged at our own processing facilities. For other agricultural products, such
as rice and edible oil, we purchase them from third-party suppliers, and sell these products at our online store Farmmi Liangpin
Market. Mainly through distributors, we offer gourmet dried mushrooms to domestic and overseas retail supermarkets, produce distributors
and foodservice distributors and operators. We have become an enterprise with advanced processing equipment and business management
experience, and we pride ourselves on consistently producing quality mushrooms and serving our customers with a high level of commitment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Currently, we estimate that approximately 94% of our products
are sold in China to domestic distributors and the remaining 6% are sold internationally, including USA, Japan, Canada and other
countries, through distributors. In addition, in order to enhance our e-commerce marketing presence, we developed our own e-commerce
website Farmmi Jicai (<U>www.farmmi88.com</U>) and online shopping mall Farmmi Liangpin Market (<I>initially www.farmmi88.com;
later switched to mobile application and mini program on WeChat; closed in December&nbsp;2020</I>). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We conduct our business through following structures:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 25%; border-bottom: black 1pt solid"><B>Structure</B></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 24%; border-bottom: black 1pt solid; text-align: center"><B>Company</B></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 24%; border-bottom: black 1pt solid; text-align: center"><B>Business</B></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 24%; border-bottom: black 1pt solid; text-align: center"><B>Related PRC Legal<BR>
Restrictions on<BR>
Foreign-owned<BR>
Entity</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Parent-subsidiary Structure</TD>
    <TD>&nbsp;</TD>
    <TD>All of our foreign-owned entity subsidiaries</TD>
    <TD>&nbsp;</TD>
    <TD>Process and/or sell agricultural products</TD>
    <TD>&nbsp;</TD>
    <TD>None</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Variable interest entity (&ldquo;VIE&rdquo;)</TD>
    <TD>&nbsp;</TD>
    <TD>Hangzhou Nongyuan Network Technology Co.,&nbsp;Ltd., a domestic company</TD>
    <TD>&nbsp;</TD>
    <TD>Operate online business</TD>
    <TD>&nbsp;</TD>
    <TD>Restrictions on operation of independent online stores (deemed as value-added telecommunication service business) by foreign-owned entities</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We conduct the vast majority of our business through a traditional
equity ownership structure, which is a parent-subsidiary structure. The vast majority of our business is processing and/or selling
agricultural products. Based on the advice of our PRC legal counsel,  PRC laws and regulations allow
foreign-owned entities to conduct such business directly, rather than through contractual VIE agreements. Our VIE had revenue of&thinsp;$4,558,854,
$6,184,460 and $3,369,258 in the year ended September&nbsp;30, 2020, 2019 and 2018, respectively. As the chart above shows, our
VIE operates only where we are not permitted to own the operating company by PRC laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1pt solid; padding-right: 5pt; padding-left: 5pt; width: 98%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%">Shares offered by the Selling Shareholder:</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 84%">Up to an aggregate 1,039,329 ordinary shares, 150% of 692,886 ordinary shares underlying the Placement Agent Warrants (as defined below), for which ordinary shares have not been registered in the 2019 Registration Statement (as defined in &ldquo;Private Placement&rdquo; in this prospectus). </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Shares outstanding prior to completion of offering:</TD>
    <TD>&nbsp;</TD>
    <TD>21,114,303 ordinary shares as of March&nbsp;16, 2021, excluding (a)&nbsp;800,000 ordinary shares underlying warrants we issued to an investor in a private placement, at an exercise price of&thinsp; $2 per share, with an expiration date of November&nbsp;1, 2022 (the &ldquo;Investor Warrants&rdquo;), (b)&nbsp;812,694 ordinary shares underlying warrants we issued to the placement agent in the same private placement, at an exercise price of&thinsp; $2 per share, with an expiration date of November&nbsp;1, 2022 (the &ldquo;Placement Agent Warrants&rdquo;), and (c)&nbsp;571,400 ordinary shares under our 2018 share incentive plan.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Shares to be outstanding after offering:</TD>
    <TD>&nbsp;</TD>
    <TD>22,153,632 ordinary shares, assuming (a)&nbsp;the issuance of 1,039,329 ordinary shares being registered in this offering, (b)&nbsp;no issuance of any ordinary shares registered by the 2019 Registration Statement underlying the Placement Agent Warrants and the Investor Warrants, and (c)&nbsp;no issuance of any ordinary shares under our 2018 share incentive plan.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Terms of this offering:</TD>
    <TD>&nbsp;</TD>
    <TD>The Selling Shareholder, including their transferees, donees, pledgees, assignees and successors-in-interest, may sell, transfer or otherwise dispose of any or all of the Shares offered by this prospectus from time to time on the Nasdaq Capital Market or any other stock exchange, market or trading facility on which the shares are traded or in private transactions. The Shares may be sold at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market price or at negotiated prices.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Use of proceeds:</TD>
    <TD>&nbsp;</TD>
    <TD>All proceeds from the sale of the Shares offered hereby will be for the account of the Selling Shareholder. We will not receive any proceeds from the sale of the Shares offered pursuant to this prospectus. We will receive proceeds upon cash exercises, if any, of the Placement Agent Warrants to purchase the Shares offered hereby. See the caption &ldquo;Use of Proceeds&rdquo; in this prospectus.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Nasdaq Capital Market Symbol:</TD>
    <TD>&nbsp;</TD>
    <TD>&ldquo;FAMI&rdquo; (CUSIP No.&nbsp;G33277 107)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Trading:</TD>
    <TD>&nbsp;</TD>
    <TD>Our ordinary shares currently trade on the Nasdaq Capital Market. There is no established trading market for the Placement Agent Warrants that are exercisable for the Shares offered hereby.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Risk factors:</TD>
    <TD>&nbsp;</TD>
    <TD>Investing in these securities involves a high degree of risk. As an investor, you should be able to bear a complete loss
    of your investment. You should carefully consider the information set forth in the &ldquo;Risk Factors&rdquo; section of this
    prospectus beginning on page <U>7</U>&nbsp; before deciding to invest in our ordinary shares.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>An investment in our securities involves
a high degree of risk. Before investing in our ordinary shares, you should carefully consider the risk factors set forth below
and those described under &ldquo;Risk Factors&rdquo; in the documents incorporated by reference herein, including in our most recent
Annual Report on Form&nbsp;20-F filed with the SEC, together with the other information included in this prospectus and incorporated
by reference herein from our filings with the SEC. If any of such risks or uncertainties occurs, our business, financial condition,
and operating results could be materially and adversely affected. Additional risks and uncertainties not currently known to us
or that we currently deem immaterial also may materially and adversely affect our business operations. As a result, the trading
price of our ordinary shares could decline and you could lose all or a part of your investment.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Risks Related to this Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Future sales of our ordinary shares
may cause the prevailing market price of our shares to decrease.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The issuance and sale of additional ordinary
shares could reduce the prevailing market price for our ordinary shares as well as make future sales of equity securities by us
less attractive or not feasible. The sale of ordinary shares issued upon the exercise of our outstanding warrants could further
dilute the holdings of our then existing shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>There has been and may continue to be
significant volatility in the volume and price of our ordinary shares on the Nasdaq Capital Market.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The market price of our ordinary shares
has been and may continue to be highly volatile. Factors, including changes in the Chinese food industry, changes in the Chinese
economy, competition, concerns about our financial position, operations results, litigation, government regulation, developments
or disputes relating to agreements or proprietary rights, may have a significant impact on the market volume and price of our stock.
Unusual trading volume in our shares occurs from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We have not paid and do not intend to
pay dividends on our ordinary shares. Investors in this offering may never obtain a return on their investment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not paid dividends on our ordinary
since inception, and do not intend to pay any dividends on our ordinary shares in the foreseeable future. We intend to reinvest
earnings, if any, in the development and expansion of our business. Accordingly, you will need to rely on sales of your ordinary
shares after price appreciation, which may never occur, in order to realize a return on your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Risks Related to the Current Pandemic</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We face risks related to health epidemics that could impact
our sales and operating results.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our business could be adversely affected by the effects of a
widespread outbreak of contagious disease, including the outbreak of respiratory illness caused by a novel coronavirus (&ldquo;COVID-19&rdquo;)
first identified in Wuhan, Hubei Province, China and declared as a pandemic by the World Health Organization in March&nbsp;2020.
Any outbreak of contagious diseases, and other adverse public health developments, particularly in China, could have a material
and adverse effect on our business operations. These could include disruptions or restrictions on our ability to our operations,
as well as temporary closures of our facilities and ports or the facilities of our customers and third-party service providers.
Any disruption or delay of our customers or third-party service providers would likely impact our operating results and the ability
of the Company to continue as a going concern. In addition, a significant outbreak of contagious diseases in the human population
could result in a widespread health crisis that could adversely affect the economies and financial markets of China and many other
countries, resulting in an economic downturn that could affect demand for our products and significantly impact our operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The COVID-19 has had a significant
impact on our operations for the year ended September&nbsp;30, 2020 and could materially adversely affect our business and financial
results for the remaining months of the 2021 fiscal year.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our ability to manufacture and/or sell our products may be impaired
by damage or disruption to our manufacturing, warehousing or distribution capabilities, or to the capabilities of our suppliers,
logistics service providers or distributors as a result of the impact from COVID-19. This damage or disruption could result from
events or factors that are impossible to predict or are beyond our control, such as raw material scarcity, pandemics, government
shutdowns, disruptions in logistics, supplier capacity constraints, adverse weather conditions, natural disasters, fire, terrorism
or other events. In December&nbsp;2019, COVID-19 emerged in Wuhan, China. Because of the shelter-in-place orders and travel restrictions
mandated by the Chinese government, the production and sales activities of the Company stopped during the end of January&nbsp;and
February&nbsp;2020, which adversely impacted the Company&rsquo;s production and sales during that period. Although the production
and sales resumed at the end of March&nbsp;2020, the COVID-19 outbreak has had a significant adverse impact on our business and
operations during the fiscal year ended September&nbsp;30, 2020. The Company&rsquo;s operations may be affected by the ongoing
outbreak of COVID-19. The continued uncertainties associated with COVID-19 may cause the Company&rsquo;s revenue and cash flows
to underperform in the next 12 months. A resurgence could negatively affect the sales, the collection of the payments from account
receivables and the utilization of advances to suppliers. The extent of the future impact of COVID-19 is still highly uncertain
and cannot be predicted as of the financial statement reporting date. If COVID-19 further impacts its production and sales, the
Company&rsquo;s financial condition, results of operations, and cash flows could continue to be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Shares are being registered for the account of the Selling
Shareholder. We will not receive any of the proceeds from the sale of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will receive proceeds from the cash exercise of the Placement
Agent Warrants which, if exercised in cash with respect to all of the 1,039,329 ordinary shares being registered here, would result
in gross proceeds of $2,078,658 to us. We will use any proceeds received by us from the cash exercise of the Placement Agent Warrants
for general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We cannot predict when or if the Placement Agent Warrants will
be exercised, and it is possible that the Placement Agent Warrants may expire and never be exercised. In addition, the Placement
Agent Warrants are exercisable on a cashless basis if at the time of exercise there is no effective registration statement registering,
or the prospectus contained therein is not available for, the issuance of the ordinary shares for which the Placement Agent Warrants
are exercisable. As a result, we may never receive meaningful, or any, cash proceeds from the cash exercise of the Placement Agent
Warrants, and we cannot plan on any specific uses of any proceeds we may receive beyond the purposes described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>PRIVATE PLACEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November&nbsp;1, 2018, we issued to an institutional investor
(a)&nbsp;senior convertible notes with an aggregate principal amount of&thinsp; $7,500,000 (the &ldquo;Notes&rdquo;) which were
initially convertible into an aggregate of 1,198,084 of the Company&rsquo;s ordinary shares at the rate of&thinsp; $6.26 per share,
and (b)&nbsp;the Investor Warrants to purchase an aggregate of 800,000 ordinary shares at an initial exercise price of&thinsp;
$6.53 per share. We also issued the Placement Agent Warrants to purchase an aggregate of 119,808 ordinary shares at an initial
exercise price of&thinsp; $7.183 per share to the placement agent (together with the Investor Warrants, the &ldquo;Warrants&rdquo;).
The Warrants may be exercised at any time after issuance and expire on November&nbsp;1, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the resale of the ordinary shares issuable upon exercise
of such Warrants is not covered by an effective registration statement or an exemption from registration, the holders of such Warrants
are afforded cashless exercise rights. In such event, the holders would pay the exercise price by surrendering the Warrants for
that number of ordinary shares equal to the quotient obtained by dividing (x)&nbsp;the product of the number of ordinary shares
underlying the Warrants, multiplied by the exercise price of the Warrants by (y)&nbsp;the daily volume weighted average price of
the ordinary shares on the primary U.S. trading market on which the ordinary shares are then listed or quoted as reported by Bloomberg
L.P. on the trading date immediately prior to the date of exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The number of ordinary shares issuable on exercise of the outstanding
Warrants and exercise price of such Warrants may be adjusted in certain circumstances including in the event of a share split or
dividend. In addition, if we subsequently complete a dilutive issuance while the Warrants are outstanding, the exercise price for
the Warrants will be reduced to the price of the dilutive issuance (but the number of shares underlying the Warrants shall not
be adjusted). We may be required to repurchase the Warrants for their Black-Scholes value in the event we engage in a fundamental
transaction like a reorganization, merger or consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Warrants may be exercised upon delivery of an exercise notice,
duly signed by the holders, accompanied by full payment of the exercise price, in U.S. dollars, in same day cleared funds that will
not be reversed, delivered into the Company&rsquo;s bank account, free and clear of any restriction, condition, set-off, deduction,
or withholding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Warrants holders do not have the rights or privileges of
holders of ordinary shares and any voting rights until they exercise their Warrants and receive ordinary shares. After the issuance
of ordinary shares upon exercise of the Warrants, each holder will be entitled to one vote for each share held of record on all
matters to be voted on by stockholders. Notwithstanding the foregoing, in the event we issue securities pro rata to the holders
of our ordinary shares, the holders of the Warrants will be entitled to acquire on the same terms such securities as it would have
been able to acquire if it had held ordinary shares rather than Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November&nbsp;1, 2018, we entered into a registration rights
agreement (the &ldquo;Registration Rights Agreement&rdquo;) with the institutional investor in connection with the private placement
transaction, pursuant to which we shall, register under the Securities Act for resale 150% shares of our ordinary shares issuable
upon the conversion or repayment of such Notes or the exercise of such Warrants. The Registration Rights Agreement contains customary
terms such as piggyback registration rights. We complied with our obligations under this registration rights agreement by filing
of a registration statement with SEC on December&nbsp;4, 2018, which was declared effective on February&nbsp;12, 2019, amended
by post-effective amendment on Form&nbsp;F-3 which was filed with SEC on November&nbsp;27, 2019 and declared effective on December&nbsp;3,
2019 (the &ldquo;2019 Registration Statement&rdquo;). The 2019 Registration Statement registered 3,459,719 ordinary shares, 150%
of an aggregate of 2,306,479 ordinary shares underlying the principal of the Notes, interest repayment of the Notes, the Investor
Warrants, and the Placement Agent Warrants (before we adjusted the number of shares underlying the Placement Agent Warrants).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: split002 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we fail, under certain circumstances to file and keep effective
a registration statement with respect to the securities covered under the Registration Rights Agreement, we have agreed to pay
liquidated damages to each investor in an amount equal to one percent (1.0%) of the aggregate amount invested by such investor
pursuant to the Notes for each 30-day period or pro rata for any portion thereof during which the failure to file or keep effective
continues. The registration rights will terminate with respect to each investor upon the date such investor ceases to hold registrable
securities under the terms of the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We repaid the Notes as of June&nbsp;22, 2020. On March&nbsp;10,
2020, we adjusted the warrant exercise price of the Warrants to $2 per share according to the terms of the Warrants. On July&nbsp;10,
2020, according to the terms of the Placement Agent Warrants, we adjusted the number of shares underlying the Placement Agent Warrants
from 119,808 to 812,694, ten percent (10%) of the number of ordinary shares actually issued by us in repayment of principal under
the Notes. We have registered 179,712 ordinary shares by the 2019 Registration Statement, 150% of 119,808 ordinary shares underlying
the Placement Agent Warrants. Therefore, we are registering 1,039,329 ordinary shares, 150% of the remaining 692,886 ordinary shares
underlying the Placement Agent Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>SELLING SHAREHOLDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are registering the Shares in order to permit the Selling
Shareholder to offer the Shares for resale from time to time. The Shares being offered by the Selling Shareholder are 1,039,329
ordinary shares, 150% of the 692,886 ordinary shares underlying the Placement Agent Warrants which have not been registered by
the 2019 Registration Statement. Except for the ownership of the Placement Agent Warrants issued pursuant to the Securities Purchase
Agreement, the Selling Shareholder have not had any material relationship with us within the past three&nbsp;years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table below lists the Selling Shareholder and other
information regarding the beneficial ownership (as determined under Section&nbsp;13(d)&nbsp;of the Securities Exchange Act of
1934, as amended (the &ldquo;Exchange Act&rdquo;), and the rules&nbsp;and regulations thereunder) of the ordinary shares held the Selling Shareholder. In
accordance with the terms of the Registration Rights Agreement, this prospectus generally covers the resale of 150% of
692,886 ordinary shares at an exercise price of $2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the terms of the Placement Agent Warrants, the Selling
Shareholder may not convert the Placement Agent Warrants to the extent (but only to the extent) such Selling Shareholder or any
of its affiliates would beneficially own a number of our ordinary shares which would exceed 4.99% of the outstanding shares of
the Company immediately after giving effect to such exercise, provided that upon at least 61&nbsp;days prior notice to us, the
holder may increase or decrease such limitation up to a maximum of 9.99% of the number of ordinary shares outstanding. The Selling
Shareholder may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid">Name of Selling Shareholder</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Number of Ordinary<BR> Shares Owned Prior to<BR> Offering <SUP>(1)</SUP></B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Maximum Number of<BR> ordinary shares to be Sold<BR> Pursuant to this Prospectus <SUP>(2)</SUP></B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><B>Number of Ordinary<BR> Shares of Owned After<BR> Offering <SUP>(3)</SUP></B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; font-size: 10pt; text-align: left">Jian Ke <SUP>(4)</SUP></TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 22%; font-size: 10pt; text-align: right">1,219,041</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 22%; font-size: 10pt; text-align: right">1,039,329</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 22%; font-size: 10pt; text-align: right">179,712</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px">(1)</TD>
    <TD>It represents 150% of 812,694 ordinary shares underlying the Placement Agent Warrants, assuming full exercise of the Placement Agent Warrants held by the Selling Shareholder. </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px">(2)</TD>
    <TD>It represents the number of shares being registered here underlying the Placement Agent Warrants, which is 150% of 692,886 ordinary shares underlying the Placement Agent Warrants.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px">(3)</TD>
    <TD>It (a)&nbsp;represents the number of shares registered in the 2019 Registration Statement, which is 150% of 119,808 ordinary shares underlying the Placement Agent Warrants, before we adjusted the number of shares underlying the Placement Agent Warrants from 119,808 to 812,694 on July&nbsp;10, 2020, and (b)&nbsp;assumes the sale of all of the Shares offered by the Selling Shareholder pursuant to this prospectus.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 24px">(4)</TD>
    <TD>The placement agent FT Global Capital,&nbsp;Inc. designated its principal Jian Ke to receive the Placement Agent Warrants. Jian Ke&rsquo;s address is C/O FT Global Capital,&nbsp;Inc., 5 Concourse Parkway, Suite&nbsp;3000, Atlanta, GA, 30328.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are registering the Shares, a portion of the ordinary shares
issuable upon exercise of the Placement Agent Warrants, to permit the resale of the Shares by the holder of the Placement Agent
Warrants from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the Selling
Shareholder of the Shares, although we will receive the exercise price of any Placement Agent Warrants exercised by the Selling
Shareholder in cash. We will bear all fees and expenses incident to our obligation to register the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Selling Shareholder may sell all or a portion of the Shares
held by it and offered hereby from time to time directly or through one or more underwriters, broker-dealers or agents. If the
Shares are sold through underwriters or broker-dealers, the Selling Shareholder will be responsible for underwriting discounts
or commissions or agent&rsquo;s commissions. The Shares may be sold in one or more transactions at fixed prices, at prevailing
market prices at the time of the sale, at varying prices determined at the time of sale or at negotiated prices. These sales may
be effected in transactions, which may involve crosses or block transactions, pursuant to one or more of the following methods:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>in the over-the-counter market;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>in transactions otherwise than on these exchanges or systems or in the over-the-counter market;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>through the writing or settlement of options, whether such options are listed on an options exchange or otherwise;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>an exchange distribution in accordance with the rules&nbsp;of the applicable exchange;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>privately negotiated transactions;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>short sales made after the date the Registration Statement is declared effective by the SEC;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>broker-dealers may agree with a selling security holder to sell a specified number of such shares at a stipulated price per share;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>a combination of any such methods of sale; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>any other method permitted pursuant to applicable law.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Selling Shareholder may also sell Shares under Rule&nbsp;144
promulgated under the Securities Act, if available, rather than under this prospectus. In addition, the Selling
Shareholder may transfer the Shares by other means not described in this prospectus. If the Selling Shareholder effects such transactions
by selling the Shares to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive
commissions in the form of discounts, concessions or commissions from the Selling Shareholder or commissions from purchasers of
the Shares for whom they may act as agent or to whom they may sell as principal (which discounts, concessions or commissions as
to particular underwriters, broker-dealers or agents may be in excess of those customary in the types of transactions involved).
In connection with sales of the Shares or otherwise, the Selling Shareholder may enter into hedging transactions with broker-dealers,
which may in turn engage in short sales of the Shares in the course of hedging in positions they assume. The Selling Shareholder
may also sell the Shares short and deliver the Shares covered by this prospectus to close out short positions and to return borrowed
shares in connection with such short sales. The Selling Shareholder may also loan or pledge the Shares to broker-dealers that in
turn may sell such Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Selling Shareholder may pledge or grant a security interest
in some or all of the Placement Agent Warrants or Shares owned by him and, if he defaults in the performance of their secured obligations,
the pledgees or secured parties may offer and sell the Shares from time to time pursuant to this prospectus or any amendment to
this prospectus under Rule&nbsp;424(b)(3)&nbsp;or other applicable provision of the Securities Act amending, if necessary, the
list of Selling Shareholder to include the pledgee, transferee or other successors in interest as selling shareholders under this
prospectus. The Selling Shareholder also may transfer and donate the Shares in other circumstances in which case the transferees,
donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the extent required by the Securities Act and the rules&nbsp;and
regulations thereunder, the Selling Shareholder and any broker-dealer participating in the distribution of the Shares may be deemed
to be &ldquo;underwriters&rdquo; within the meaning of the Securities Act, and any commission paid, or any discounts or concessions
allowed to, any such broker-dealer may be deemed to be underwriting commissions or discounts under the Securities Act. At the time
a particular offering of the Shares is made, a prospectus supplement, if required, will be distributed, which will set forth the
aggregate amount of Shares being offered and the terms of the offering, including the name or names of any broker-dealers or agents,
any discounts, commissions and other terms constituting compensation from the Selling Shareholder and any discounts, commissions
or concessions allowed or re-allowed or paid to broker-dealers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the securities laws of some states, the Shares may be
sold in such states only through registered or licensed brokers or dealers. In addition, in some states the Shares may not be sold
unless such Shares have been registered or qualified for sale in such state or an exemption from registration or qualification
is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There can be no assurance that the Selling Shareholder will
sell any or all of the Shares registered pursuant to the registration statement, of which this prospectus forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Selling Shareholder and any other person participating in
such distribution will be subject to applicable provisions of the Exchange Act, and the rules&nbsp;and
regulations thereunder, including, without limitation, to the extent applicable, Regulation&nbsp;M of the Exchange Act, which may
limit the timing of purchases and sales of any of the Shares by the Selling Shareholder and any other participating person. To
the extent applicable, Regulation&nbsp;M may also restrict the ability of any person engaged in the distribution of the Shares
to engage in market-making activities with respect to the Shares. All of the foregoing may affect the marketability of the Shares
and the ability of any person or entity to engage in market-making activities with respect to the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will pay all expenses of the registration of the Shares pursuant
to the Registration Rights Agreement, estimated to be $36,227 in total, including, without limitation, Securities and Exchange
Commission filing fees and expenses of compliance with state securities or &ldquo;blue sky&rdquo; laws; provided, however, the
Selling Shareholder will pay all underwriting discounts and selling commissions, if any. We will indemnify the Selling Shareholder
against liabilities, including some liabilities under the Securities Act in accordance with the Registration Rights Agreement or
the Selling Shareholder will be entitled to contribution. We may be indemnified by the Selling Shareholder against civil liabilities,
including liabilities under the Securities Act that may arise from any written information furnished to us by the Selling Shareholder
specifically for use in this prospectus, in accordance with the related registration rights agreements or we may be entitled to
contribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Once sold under the registration statement, of which this prospectus
forms a part, the Shares will be freely tradable in the hands of persons other than our affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>EXPENSES RELATING TO THIS OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Set forth below is an itemization of the total expenses, excluding
underwriting discounts and commissions, that we expect to incur in connection with this offering. With the exception of the SEC
registration fee, all amounts are estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 88%">Securities and Exchange Commission Registration Fee</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">$</TD>
    <TD STYLE="width: 9%; text-align: right">226.78</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>Legal Fees and Expenses</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">25,000.00</TD>
    <TD>*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>Accounting Fees and Expenses</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="color: #333333">10,000.00</FONT></TD>
    <TD>*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-bottom: 1pt">Miscellaneous Expenses</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="color: #333333">1,000.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 2.5pt">Total Expenses</TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2.25pt double">$</TD>
    <TD STYLE="border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="color: #333333">36,226.78</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">*</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #333333">* Estimated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Campbells, Grand Cayman, Cayman Islands will pass upon the validity
of the securities offered in this offering. The address of Campbells is Floor 4, Willow House, Cricket Square, Grand Cayman KY1-9010,
Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The financial statements incorporated by reference in this prospectus
for the year ended September&nbsp;30, 2020 have been audited by Friedman LLP, an independent registered public accounting firm,
as set forth in their report thereon included therein, and incorporated herein by reference, and are included in reliance upon
such report given on the authority of such firm as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_013"></A>ENFORCEABILITY OF CIVIL LIABILITIES<BR>
UNDER UNITED STATES FEDERAL SECURITIES&nbsp;LAWS AND OTHER MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are registered under the laws of the Cayman Islands as an
exempted company with limited liability. We are registered in the Cayman Islands because of certain benefits associated with being
a Cayman Islands exempted company, such as political and economic stability, an effective judicial system, a favorable tax system,
the absence of exchange control or currency restrictions and the availability of professional and support services. However, the
Cayman Islands has a less developed body of securities laws as compared to the United States and provides protections for investors
to a lesser extent. In addition, Cayman Islands companies may not have standing to sue before the federal courts of the United
States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Substantially all of our assets are located outside the United
States. In addition, a majority of our directors and officers are nationals and/or residents of countries other than the United
States, and all or a substantial portion of such persons&rsquo; assets are located outside the United States. As a result, it may
be difficult for investors to effect service of process within the United States upon us or such persons or to enforce against
them or against us, judgments obtained in United States courts, including judgments predicated upon the civil liability provisions
of the securities laws of the United States or any state thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have appointed CT Corporation System (28 Liberty St. New
York, NY 10005) as our agent to receive service of process with respect to any action brought against us in the United States District
Court for the Southern District of New York under the federal securities laws of the United States or under the securities laws
of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have been advised by our PRC
counsel that there is uncertainty as to whether the courts of the PRC would enforce judgments of United States courts or Cayman
courts obtained against us or these persons predicated upon the civil liability provisions of the United States federal and state
securities laws. Our PRC counsel has further advised us that the recognition and enforcement of foreign judgments are
provided for under PRC Civil Procedures Law. PRC courts may recognize and enforce foreign judgments in accordance with the requirements
of PRC Civil Procedures Law based either on treaties between China and the country where the judgment is made or on reciprocity
between jurisdictions. China does not have any treaties or other form of reciprocity with the United States or the Cayman Islands
that provide for the reciprocal recognition and enforcement of foreign judgments. In addition, according to the PRC Civil Procedures
Law, courts in the PRC will not enforce a foreign judgment against us or our directors and officers if they decide that the judgment
violates the basic principles of PRC law or national sovereignty, security or public interest. As a result, it is uncertain whether
and on what basis a PRC court would enforce a judgment rendered by a court in the United States or in the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Cayman Islands counsel has informed us that the uncertainty
with regard to Cayman Islands law relates to whether a judgment obtained from the United States courts under civil liability provisions
of the securities laws will be determined by the courts of the Cayman Islands as penal or punitive in nature. If such a determination
is made, the courts of the Cayman Islands will not recognize or enforce the judgment against a Cayman Islands&rsquo; company. Because
the courts of the Cayman Islands have yet to rule&nbsp;on whether such judgments are penal or punitive in nature, it is uncertain
whether they would be enforceable in the Cayman Islands. Our Cayman Islands counsel has further advised us that a final and conclusive
judgment in the federal or state courts of the United States under which a sum of money is payable, other than a sum payable in
respect of taxes, fines, penalties or similar charges, may be subject to enforcement proceedings as a debt in the courts of the
Cayman Islands under the common law doctrine of obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_014"></A>DISCLOSURE OF COMMISSION POSITION ON
INDEMNIFICATION FOR SECURITIES ACT LIABILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have
been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and
is therefore unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_015"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are a reporting company and file annual, quarterly and current
reports, proxy statements and other information with the SEC. This prospectus does not contain all of the information set forth
in the registration statement or the exhibits that are a part of the registration statement. You may read and copy the registration
statement and any document we file with the SEC at the public reference room maintained by the SEC at 100 F Street, N.E., Washington,
D.C. 20549. You may obtain information on the operation of the public reference room by calling the SEC at 1-800-SEC-0330. Our
filings with the SEC are also available to the public through the SEC&rsquo;s Internet site at <U>http://www.sec.gov</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_016"></A>INFORMATION INCORPORATED BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The SEC allows us to &ldquo;incorporate by reference&rdquo;
into this prospectus the information we file with them. The information we incorporate by reference into this prospectus is an
important part of this prospectus. Any statement in a document we have filed with the SEC prior to the date of this prospectus
and which is incorporated by reference into this prospectus will be considered to be modified or superseded to the extent a statement
contained in this prospectus or any other subsequently filed document that is incorporated by reference into this prospectus modifies
or supersedes that statement. The modified or superseded statement will not be considered to be a part of this prospectus, except
as modified or superseded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We incorporate by reference into this prospectus the information
contained in the following documents that we have filed with the SEC pursuant to the Exchange Act, which is considered to be a part of this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>Our Annual Report on Form&nbsp;20-F for the year ended September&nbsp;30, 2020, filed on <A HREF="https://www.sec.gov/Archives/edgar/data/1701261/000110465921009423/tm213389d1_20f.htm" STYLE="-sec-extract: exhibit">January&nbsp;29, 2021</A>; and</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>Our Current Report on Form&nbsp;6-K furnished on <A HREF="http://www.sec.gov/Archives/edgar/data/1701261/000110465921032701/tm218822d1_6k.htm" STYLE="-sec-extract: exhibit">March&nbsp;5,
    2021</A>; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&middot;</FONT></TD>
    <TD>The description of our ordinary shares contained in our registration statement on Form&nbsp;8-A filed on <A HREF="https://www.sec.gov/Archives/edgar/data/1701261/000114420418007353/tv485715_8a12b.htm" STYLE="-sec-extract: exhibit">February&nbsp;12, 2018</A> and as it may be further amended from time to time.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All
documents that we file with the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (and in the case of a Current
Report on Form 6-K, so long as <FONT STYLE="background-color: white">they state that they are incorporated by reference into this
prospectus, and</FONT> other than Current Reports on Form 6-K, or portions thereof, furnished under Form 6-K) (i) after the initial
filing date of the registration statement of which this prospectus forms a part and prior to the effectiveness of such registration
statement and (ii) after the date of this prospectus and prior to the termination of the offering shall be deemed to be incorporated
by reference in this prospectus from the date of filing of the documents, unless we specifically provide otherwise. Information
that we file with the SEC will automatically update and may replace information previously filed with the SEC. To the extent that
any information contained in any Current Report on Form 6-K or any exhibit thereto, was or is furnished to, rather than filed
with the SEC, such information or exhibit is specifically not incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You
may obtain a copy of these filings, without charge, by writing or calling us at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Fl 1, Building
No.&nbsp;1, 888 Tianning Street,&nbsp;Liandu District</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Lishui, Zhejiang
Province</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>People&rsquo;s
Republic of China 323000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>+86-057-82612876
 &mdash; telephone</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Attn: Investor Relations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2113755-1_424b3img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2113755-1_424b3img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !_ 1X# 2(  A$! Q$!_\0
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M*O\ P5$N,2Q_LJ^)/+D2)X735=-DWQ"'_7<_9#_^L$>E1M_P14_X*B([1_\
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M#=SFOU9\1>)+#PUI.JZQJ5Q#9Z9H6G76KZI<W+^7';:78V=Q//-Y_': D]>
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MIN\:A_PCWV'_ $JUX'MWV/UCBSB2& PW/1K;GY;HS1XVNW^NEF^__P M9_\
MEMW_ ,>_49K[$_X)_P :O^VE^S?Q_P U(TK']/Y?GS7R5'83-;6^J?9;R30_
M.$-YJ2)FWMI?^>/G=SWKZW_8"_<_MG?LWLW_ $4C2^4]1^N?7-<Y^'Y73A1Q
MF6^V_P"8C&?7/^YS\C][?^#K3_DX;]F#_LG6L?\ J0&OR2_X(J_\I1?V4/\
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M)X;/L9.=;ZNL3]3_ -C_ .Y/!_J?1/\ P=A2YU3]C^%?XH/%LN_^_'YUB?\
M/OG'7-?RR_LRB&__ &C/@+;W5K:S6MY\2_"5G>6<UMYEO>6L\T$%Q#/!<?YX
MZ5_4O_P=>A/MO[(.W<S6I\4V#F-.$DSI7G=/19[?/U/UK^6[]E^VD'[2?P!6
M/*[?BOX-^2;/F?\ 'Y!C\\9]/PKJ.CC"-&?$^#_[D_Z_K[C_ %7O#7[/GP4;
MP_I"GX6>  G]EZ9]_P *:%)_S#H,<_V=UP"#QR<_2OYM_P#@X_\ V!O#6J_
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M.GY=_K^@YJ,C*8^;/'&\_P"?\G'6B_\ 7XGD8_)<!F555<90]O96MV1^4_\
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MQ0^&^F74NEZIX\\(:=J4+E+FPO\ Q5HUO>I_UV@N;G[1Z]2./2K/A?QMX/\
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M;2Y_X]_^74?Z'P0+*O@G39KK2[_2=4T]K>.^T;4K76+-T6:/9+87GVZQ_P#
M6XK^D9/^"7G_  1KQ\G_  4\\3*K)+#Y::#9_/%]/[$Q^O.3Z4'_ ()=?\$:
M8X=J_P#!3KQ5M_@0^$K.XV9_YX3G3?M/^ %!RXC)\XQ];ZSB:WUBO_70^-+'
M_@O;_P %,=*L-)TG3OB[HZ6.D6=KIMFDVB0B4V-C#!!!]H^SVWV;[1]G@/\
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M\,K^TYI?[1EU\;EAEA\;?\(EXDTS3_#:77]I7WV'^RK&XMOM-O\ \2?^R?\
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MNF_"WQ'"]]'%Y>IZE=>5!!]MOKZYN+K4[\\_\O=V1G!'4Y_B2_X(M&W'[?\
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MU.MBWB--VK'^.5%X6\4FPMT7PGXJW;-ES]FT>\DWQ?\ @-SU_P :_4#X6_\
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M4-'^$OPSTG4+=HY;:_TKP%X6TZ[@E0[UEM[FUTQ)X6#?=*,K*>AYS3YH=O\
MR4[\1P;B,9B/;8S&_6'V::_4W?AO8W6E_#GP'IM]'Y-[I_@[PQ8WD1ZQ7-KH
F=C!<1#TV31,/PKNZC/!4#L<_K_\ KJ2LWN?>07)"G#LK?A<__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
